Ontogeny of drug elimination by the human kidney

被引:103
作者
Chen, N
Aleksa, K
Woodland, C
Rieder, M
Koren, G
机构
[1] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada
[2] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Fac Med, Dept Pharmacol, Toronto, ON, Canada
[4] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol & Pediat, London, ON, Canada
[5] Childrens Hosp Western Ontario, Dept Pediat, London, ON, Canada
关键词
kidney; ontogeny; renal clearance; glomerular filtration; tubular secretion; dosages; toddlerhood;
D O I
10.1007/s00467-005-2105-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Renal clearance is an important route of drug elimination. While during the neonatal period there is minimal glomerular filtration and active tubular secretion of drugs, there is a well-described rapid development in these processes in the post-neonatal period. A less appreciated fact is that during toddlerhood, there is an "overshoot" of the glomerular filtration rate (GFR) well above the levels encountered in older children and adults, and there is an early achievement of adult levels in active drug secretion, which stays at a plateau throughout childhood and adulthood with an "overshoot" in toddlers due to specific transport mechanisms. This phenomenon leads to dose requirements for renally excreted drugs in this age group being, on a per-kilogram basis, much larger than in adults. This review discusses the mechanisms related to renal ontogeny in drug handling.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 80 条
  • [41] Impact of ontogeny on linezolid disposition in neonates and infants
    Kearns, GL
    Jungbluth, GL
    Abdel-Rahman, SM
    Hopkins, NK
    Welshman, IR
    Grzebyk, RP
    Bruss, JB
    van den Anker, JN
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (05) : 413 - 422
  • [42] Developmental pharmacology - Drug disposition, action, and therapy in infants and children
    Kearns, GL
    Abdel-Rahman, SM
    Alander, SW
    Blowey, DL
    Leeder, JS
    Kauffman, RE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) : 1157 - 1167
  • [43] Estimation of glomerular filtration rate in children
    Léger, F
    Bouissou, F
    Coulais, Y
    Tafani, M
    Chatelut, E
    [J]. PEDIATRIC NEPHROLOGY, 2002, 17 (11) : 905 - 909
  • [44] CAPTOPRIL PHARMACOKINETICS, BLOOD-PRESSURE RESPONSE AND PLASMA-RENIN ACTIVITY IN NORMOTENSIVE CHILDREN WITH RENAL SCARRING
    LEVY, M
    KOREN, G
    KLEIN, J
    MCLORIE, G
    BALFE, JW
    [J]. DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1991, 16 (04): : 185 - 193
  • [45] Li MX, 2002, J NEPHROL, V15, P614
  • [46] LISALO E, 1977, CLIN PHARMACOKINET, V2, P1
  • [47] RECURRENT POISONINGS AMONG PEDIATRIC POISONING VICTIMS
    LITOVITZ, TL
    FLAGLER, SL
    MANOGUERRA, AS
    VELTRI, JC
    WRIGHT, L
    [J]. MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1989, 4 (05): : 381 - 386
  • [48] Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney
    Mahmood, B
    Daood, MJ
    Hart, C
    Hansen, TWR
    Watchko, JF
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2001, 49 (03) : 250 - 257
  • [49] Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose
    Mamzoridi, K
    Kasteridou, N
    Peonides, A
    Niopas, I
    [J]. PHARMACOLOGY & TOXICOLOGY, 1996, 78 (06): : 417 - 420
  • [50] MARCHI AG, 1991, VET HUM TOXICOL, V33, P244